31.05.2013 Views

Come si dovrebbe fare e valutare il Test di Provocazione ... - RIAP

Come si dovrebbe fare e valutare il Test di Provocazione ... - RIAP

Come si dovrebbe fare e valutare il Test di Provocazione ... - RIAP

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

TEST DI PROVOCAZIONE ORALE PER ALIMENTI<br />

16<br />

75 Bock SA, Atkins FM. Patterns of food hypersen<strong>si</strong>tivity during<br />

<strong>si</strong>xteen years of double-blind, placebo-controlled food<br />

challenges. J Pe<strong>di</strong>atr 1990;117:561-7.<br />

76 Niggemann B, Sielaff B, Beyer K, Binder C, Wahn U. Outcome<br />

of double-blind, placebo-controlled food challenge<br />

tests in 107 ch<strong>il</strong>dren with atopic dermatitis. Clin Exp Allergy<br />

1999;29:91-6.<br />

77 Mofi <strong>di</strong> S, Bock SA, eds. A Health Profes<strong>si</strong>onal’s Guide to Food<br />

Challenges. Fairfax, VA: The Food Allergy & Anaphylaxis Network<br />

2004.<br />

78 Sampson HA, Albergo R. Comparison of results of skin tests,<br />

RAST, and double-blind, placebo-controlled food challenges<br />

in ch<strong>il</strong>dren with atopic dermatitis. J Allergy Clin Immunol<br />

1984;74:26-33.<br />

79 Niggemann B, Wahn U, Sampson HA. Proposals for standar<strong>di</strong>zation<br />

of oral food challenge tests in infants and ch<strong>il</strong>dren.<br />

Pe<strong>di</strong>atr Allergy Immunol 1994;5:11-3.<br />

80 American College of Allergy and Immunology. Guidelines<br />

for study of adverse reactions to food. Ann Allergy<br />

1991;67:299-300.<br />

81 Martelli A, Bouygue GR, Isoar<strong>di</strong> P, Marelli O, Sarratud T, Fiocchi<br />

A. Oral food challenges in ch<strong>il</strong>dren in Italy. Allergy<br />

2005;60:907-11.<br />

82 Rance F, Kanny G, Dutau G, Moneret-Vautrin D. Food hypersen<strong>si</strong>tivity<br />

in ch<strong>il</strong>dren: clinical aspects and <strong>di</strong>stribution of<br />

allergens. Pe<strong>di</strong>atr Allergy Immunol 1999;10:33-8.<br />

83 Rance F, Dutau G. Labial food challenge in ch<strong>il</strong>dren with<br />

food allergy. Pe<strong>di</strong>atr Allergy Immunol 1997;8:41-4.<br />

84 Taylor SL, Hefl e SL, Bindslev-Jensen C, Bock SA, Burks AW<br />

Jr, Christie L, et al. Factors affecting the determination of<br />

threshold doses for allergenic foods: how much is too<br />

much? J Allergy Clin Immunol 2002;109:24-30.<br />

85 Crevel RW, Ballmer-Weber BK, Holzhauser T, Hourihane<br />

JO, Knulst AC, Mackie AR,, et al. Thresholds for food allergens<br />

and their value to <strong>di</strong>fferent stakeholders. Allergy<br />

2008;63:597-609.<br />

86 Niggemann B, Reibel S, Roehr C, Felger D, Ziegert M, Sommerfeld<br />

C, et al. Pre<strong>di</strong>ctors of po<strong>si</strong>tive food challenge outcome<br />

in non-IgE-me<strong>di</strong>ated reactions to food in ch<strong>il</strong>dren with<br />

atopic dermatitis. J Allergy Clin Immunol 2001;108:1053-8.<br />

87 Sicherer SH, Morrow EH, Sampson HA. Dose-response in<br />

double-blind, placebo-controlled oral food challenges<br />

in ch<strong>il</strong>dren with atopic dermatitis. J Allergy Clin Immunol.<br />

2000;105:582-6.<br />

88 Wen<strong>si</strong>ng M, Penninks AH, Hefl e SL, et al. The range of minimum<br />

provoking doses in hazelnut-allergic patients as determined<br />

by double-blind, placebo-controlled food challenges.<br />

Clin Exp Allergy 2002;32:1757-62.<br />

89 W<strong>il</strong>liams LW, Bock SA. Skin testing and food challenges in<br />

allergy. Clin Rev Allergy Immunol 1999;17:323-38.<br />

90 Kok EE, Meijer Y, Kentie PA, Pasmans SGM, Knulst AC, Hoekstra<br />

MO. Oropharyngeal symptoms pre<strong>di</strong>ct objective symptoms<br />

in double-blind placebo-controlled food challenges<br />

to cow’s m<strong>il</strong>k. Allergy 2009;64:1226-7.<br />

91 Niggeman B, Beyer K. Pitfall in double blind placebo controlled<br />

food challenge. Allergy 2007;62:729-32.<br />

92 Sampson HA, Mc Casc<strong>il</strong>l CC. Food hypersen<strong>si</strong>tivity and<br />

atopic dermatitis. Evaluation of 113 patients. J Pe<strong>di</strong>atr<br />

1985;107:669-75.<br />

93 Burks AW, Sampson HA. Diagnostic approaches to the patient<br />

with suspected food allergies. J Pe<strong>di</strong>atr 1992;121:S64-<br />

S71.<br />

94 Huijbers GB, Colen AA, Jansen JJ, Kar<strong>di</strong>naal AF, Vlieg-Boerstra<br />

BJ, Martens BP. Masking foods for food challenge: practical<br />

aspects of masking foods for adouble-blind, placebocontrolled<br />

food challenge. J Am Diet Assoc 1994;94:645-9.<br />

95 Busse PJ, Nowak-Wegrzyn AH, Noone SA, Sampson HA,<br />

Sicherer SH. Recurrent peanut allergy. N Engl J Med<br />

2002;347:1535-6.<br />

96 Fleischer DM, Conover-Walker MK, Christie L, Burks AW, Wood<br />

RA. Peanut allergy: recurrence and its management. J Allergy<br />

Clin Immunol 2004;114:1195-201.<br />

97 Eigenmann PA, Caubet JC, Zamora SA. Continuing foodavoidance<br />

<strong>di</strong>ets after negative food challenges. Pe<strong>di</strong>atr<br />

Allergy Immunol 2006;17:601-5.<br />

98 Devenney I, Norrman G, Oldaeus G, Stromberg L, Falth-<br />

Magnusson K. A new model for low-dose food challenge<br />

in ch<strong>il</strong>dren with allergy to m<strong>il</strong>k or egg. Acta Pae<strong>di</strong>atrica<br />

2006;95:1133-9.<br />

99 Edwards HE. Oral desen<strong>si</strong>tization in food allergy. Cana<strong>di</strong>an<br />

Me<strong>di</strong>cal Association Journal 1940;234-6.<br />

100 Finkelstein A. Kuhm<strong>il</strong>ch als Ursache akuter Ernährungsstörungen.<br />

Sauglingen Monat für Kinderhe<strong>il</strong> 1905;4:65-72.<br />

101 Patriarca G, Nucera E, Roncallo R, Pollastrini E, Bartolozzi F,<br />

De Pasquale T, et al. Oral desen<strong>si</strong>tizing treatment in food<br />

allergy: clinical and immunological results. Aliment Pharmacol<br />

Ther 2003;17:459-65.<br />

102 Meglio P, Bartone E, Plantamura M, Arabico E, Giampietro<br />

PG. A protocol for oral desen<strong>si</strong>tization in ch<strong>il</strong>dren with IgEme<strong>di</strong>ated<br />

cow’s m<strong>il</strong>k allergy. Allergy 2004;59:980-7.<br />

103 Enrique E, Pineda F, Malek T, Bartra J, Basagaña M, Tella R,<br />

et al. Sublingual immunotherapy for hazelnut food allergy:<br />

a randomized, double-blind, placebo-controlled study with<br />

a standar<strong>di</strong>zed hazelnut extract. J Allergy Clin Immunol<br />

2005;116:1073-9.<br />

104 Fernandez Rivas M, Garrido Fernandez S, Nadal JA, Alonso<br />

Diaz de Durana MD, Garcia BE Gonzalez-Manchebo E, et<br />

al. Randomized double-blind, placebo-controlled trial of<br />

sublingual immunotherapy with Pru p3 quantifi ed peach<br />

extract. Allergy 2009;64:876-83.<br />

105 Morisset M, Moneret-Vautrin DA, Guenard L, Cuny JM, Frentz<br />

P, Hatahet R, et al. Oral desen<strong>si</strong>tization in ch<strong>il</strong>dren with m<strong>il</strong>k<br />

and egg allergies obtains recovery in a <strong>si</strong>gnifi cant proportion<br />

of cases. A randomized study in 60 ch<strong>il</strong>dren with cow’s<br />

m<strong>il</strong>k allergy and 90 ch<strong>il</strong>dren with egg allergy. Eur Ann Allergy<br />

Clin Immunol 2007;39:12-9.<br />

106 Staden U, Rolink-Werninghaus C, Brewer F, Wahn U, Niggemann<br />

B, Beyer K. Specifi c oral tolerance induction in food<br />

allergy in ch<strong>il</strong>dren: effi cacy and clinical pattern of reaction.<br />

Allergy 2007;62:1261-9.<br />

107 Longo G, Barbi E, Berti I, Meneghetti R, Pittalis A, Ronfani L, et<br />

al. Specifi c oral tolerance induction in ch<strong>il</strong>dren with very severe<br />

cow’s m<strong>il</strong>k-induced reactions. J Allergy Clin Immunol<br />

2008;121:343-7.<br />

108 Skripak JM, Nash SD, Rowley H, Brereton NH, Oh S, Ham<strong>il</strong>ton<br />

RG, et al. A randomized, double blind, plecebo-controlled<br />

study of m<strong>il</strong>k oral immunotherapy for cow’s m<strong>il</strong>k allergy. J<br />

Allergy Clin Immunol 2007;120:1172-7.<br />

109 Calvani M, Giorgio V, Miceli Sopo S. Specifi c oral tolerance<br />

induction for food. A systematic review. Eur Ann Allergy Clin<br />

Immunol 2009; in press<br />

110 Yokum MW, Butterfi eld JH, Klein JS, Volcheck GW, Schroder<br />

DR, S<strong>il</strong>verstein MD. Epidemiology of anaphylaxis in Olmsted<br />

County: a population-based study. J Allergy Clin Immunol<br />

1999;104:452-6.<br />

111 Calvani M, Di Lallo D, Spinelli A, Polo A, Zicari AM, Zappala<br />

D. Hospitalizations for pe<strong>di</strong>atric anaphylaxis. Int J Immunopathol<br />

Pharmacol 2008;21:975-81.<br />

112 Peng MM, Jick H. A population-based study of the incidence,<br />

cause and severity of anaphylaxis in the United<br />

Kingdom. Arch Int Med 2004;164:317-9.<br />

113 Beyer K, Wahn U. Immunotherapy for food allergy in ch<strong>il</strong>dren.<br />

Curr Opin Allergy Clin Immunol 2008;8:553-6.<br />

114 Sampson HA. Anaphylaxis and Emergency treatment.<br />

Pe<strong>di</strong>atrics 2003;111:1601-8.<br />

115 Simons FER, Gu X, Simons KJ. Epinephrine absorption in<br />

adults: intramuscular versus subcutaneous injection. J Allergy<br />

Clin Immunol 2001;108:871-3.<br />

116 Kemp SF, Lockey RF, Simons FER, on behalf of the World Allergy<br />

Organization ad hoc Committee on Epinephrine in<br />

Anaphylaxis. Epinephrine: the drug of choice for anaphylaxis.<br />

A Statement of the World Allergy Organization. Allergy<br />

2008;63:1061-70.<br />

117 Clark AT, Ewan PW. The prevention and management of<br />

anaphylaxis in ch<strong>il</strong>dren. Current Pae<strong>di</strong>atrics 2002;12:370-5.<br />

118 Nolan J, Baskett P. ERC Guidelines for Resuscitation 2005.<br />

Oxford: Elsevier 2005.<br />

119 Lieberman P, Kemp SF, Oppenheimer J, Lang DM, Bernstein<br />

IL, Nicklas RA, et al. The <strong>di</strong>agno<strong>si</strong>s and management of anaphylaxis:<br />

an updated practice parameter. J Allergy Clin<br />

Immunol 2005;115:s483-523.<br />

<strong>Come</strong> <strong>si</strong> <strong>dovrebbe</strong> <strong>fare</strong> e <strong>valutare</strong> <strong>il</strong> <strong>Test</strong> <strong>di</strong> provocazione orale per alimenti. Norme pratiche <strong>di</strong> comportamento

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!